Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 132

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Molecular Events for Promotion of Vancomycin Resistance in Vancomycin Intermediate Staphylococcus aureus

Hu, Qiwen, Peng, Huagang, Rao, Xiancai·2016·Frontiers in Microbiology

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fmicb.2016.01601

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Research works printed but not linked: 129

  1. Alexander, 2014, Intermediate-type vancomycin resistance (VISA) in genetically-distinct Staphylococcus aureus isolates is linked to specific, reversible metabolic alterations, PLoS ONE, 9, e97137, 10.1371/journal.pone.0097137 · DOI · Paper page
  2. Antony, 2014, Case series describing an outbreak of highly resistant vancomycin Staphylococcus aureus (possible VISA/VRSA) infections in orthopedic related procedures in Guatemala, Infect. Disord. Drug Targets, 14, 44, 10.2174/1871526514666140522115220 · doi:10.2174/1871526514666140522115220
  3. Atilano, 2010, Teichoic acids are temporal and spatial regulators of peptidoglycan cross-linking in Staphylococcus aureus, Proc. Natl. Acad. Sci. U.S.A., 107, 18991, 10.1073/pnas.1004304107 · DOI · Paper page
  4. Bae, 2006, Allelic replacement in Staphylococcus aureus with inducible counter-selection, Plasmid, 55, 58, 10.1016/j.plasmid.2005.05.005 · DOI · Paper page
  5. Belcheva, 2009, DNA-binding activity of the vancomycin resistance associated regulator protein VraR and the role of phosphorylation in transcriptional regulation of the vraSR operon, Biochemistry, 48, 5592, 10.1021/bi900478b · DOI
  6. Beltramini, 2009, Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase, Infect. Immun., 77, 1406, 10.1128/IAI.01499-08 · DOI
  7. Berscheid, 2014, Generation of a vancomycin-intermediate Staphylococcus aureus (VISA) strain by two amino acid exchanges in VraS, J. Antimicrob. Chemother., 69, 3190, 10.1093/jac/dku297 · DOI
  8. Bischoff, 2016, Stk1-mediated phosphorylation stimulates the DNA-binding properties of the Staphylococcus aureus SpoVG transcriptional factor, Biochem. Biophys. Res. Commun., 473, 1223, 10.1016/j.bbrc.2016.04.044 · DOI
  9. Boyle-Vavra, 2013, VraT/YvqF is required for methicillin resistance and activation of the VraSR regulon in Staphylococcus aureus, Antimicrob. Agents Chemother., 57, 83, 10.1128/AAC.01651-12 · DOI
  10. Cameron, 2012, Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus, J. Infect. Dis., 205, 1677, 10.1093/infdis/jis252 · DOI
  11. Campbell, 2012, An antibiotic that inhibits a late step in wall teichoic acid biosynthesis induces the cell wall stress stimulon in Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 1810, 10.1128/AAC.05938-11 · DOI
  12. Canova, 2014, A novel mode of regulation of the Staphylococcus aureus Vancomycin-resistance-associated response regulator VraR mediated by Stk1 protein phosphorylation, Biochem. Biophys. Res. Commun., 447, 165, 10.1016/j.bbrc.2014.03.128 · DOI
  13. Chan, 2013, Staphylococcus aureus mutants lacking the LytR-CpsA-Psr family of enzymes release cell wall teichoic acids into the extracellular medium, J. Bacteriol., 195, 4650, 10.1128/JB.00544-13 · DOI
  14. Chen, 2015, Multiple pathways of cross-resistance to glycopeptides and daptomycin in persistent MRSA bacteraemia, J. Antimicrob. Chemother., 70, 2965, 10.1093/jac/dkv225 · DOI
  15. Chen, 2014, Reduced susceptibility to vancomycin in isogenic Staphylococcus aureus strains of sequence type 59: tracking evolution and identifying mutations by whole-genome sequencing, J. Antimicrob. Chemother., 69, 349, 10.1093/jac/dkt395 · DOI
  16. Chen, 2016, Transcriptional profiling of the two-component regulatory system VraSR in Staphylococcus aureus with low-level vancomycin resistance, Int. J. Antimicrob. Agents, 47, 362, 10.1016/j.ijantimicag.2016.02.003 · DOI
  17. Cluzel, 2010, The Staphylococcus aureus autoinducer-2 synthase LuxS is regulated by Ser/Thr phosphorylation, J. Bacteriol., 192, 6295, 10.1128/JB.00853-10 · DOI
  18. Cui, 2006, Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 428, 10.1128/AAC.50.2.428-438.2006 · DOI · Paper page
  19. Cui, 2005, DNA microarray-based identification of genes associated with glycopeptide resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 49, 3404, 10.1128/AAC.49.8.3404-3413.2005 · DOI
  20. Cui, 2003, Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus, J. Clin. Microbiol., 41, 5, 10.1128/JCM.41.1.5-14.2003 · DOI · Paper page
  21. Cui, 2000, Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50, Antimicrob. Agents Chemother., 44, 2276, 10.1128/AAC.44.9.2276-2285.2000 · DOI · Paper page
  22. Cui, 2009, Contribution of vraSR and graSR point mutations to vancomycin resistance in vancomycin-intermediate Staphylococcus aureus, Antimicrob. Agents Chemother., 53, 1231, 10.1128/AAC.01173-08 · DOI
  23. Dayan, 2016, Staphylococcus aureus: the current state of disease, pathophysiology and strategies for prevention, Expert Rev. Vaccines., 10.1080/14760584.2016.1179583 · DOI
  24. Débarbouillé, 2009, Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus, J. Bacteriol., 191, 4070, 10.1128/JB.01813-08 · DOI
  25. Delauné, 2012, The WalKR system controls major staphylococcal virulence genes and is involved in triggering the host inflammatory response, Infect. Immun., 80, 3438, 10.1128/IAI.00195-12 · DOI · Paper page
  26. Didelot, 2016, Within-host evolution of bacterial pathogens, Nat. Rev. Microbiol., 14, 150, 10.1038/nrmicro.2015.13 · DOI · Paper page
  27. Ding, 2014, Metabolic sensor governing bacterial virulence in Staphylococcus aureus, Proc. Natl. Acad. Sci. U.S.A., 111, E4981, 10.1073/pnas.1411077111 · DOI
  28. Dmitriev, 2004, Tertiary structure of Staphylococcus aureus cell wall murein, J. Bacteriol., 186, 7141, 10.1128/JB.186.21.7141-7148.2004 · DOI
  29. Donat, 2009, Transcriptome and functional analysis of the eukaryotic-type serine/threonine kinase PknB in Staphylococcus aureus, J. Bacteriol., 191, 4056, 10.1128/JB.00117-09 · DOI
  30. Dubrac, 2008, A matter of life and death: cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway, Mol. Microbiol., 70, 1307, 10.1111/j.1365-2958.2008.06483.x · DOI · Paper page
  31. Dubrac, 2007, New insights into the WalK/WalR (YycG/YycF) essential signal transduction pathway reveal a major role in controlling cell wall metabolism and biofilm formation in Staphylococcus aureus, J. Bacteriol., 189, 8257, 10.1128/JB.00645-07 · DOI · Paper page
  32. Ernst, 2011, Broad-spectrum antimicrobial peptide resistance by MprF-mediated aminoacylation and flipping of phospholipids, Mol. Microbiol., 80, 290, 10.1111/j.1365-2958.2011.07576.x · DOI · Paper page
  33. Falord, 2012a, GraXSR proteins interact with the VraFG ABC transporter to form a five-component system required for cationic antimicrobial peptide sensing and resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 56, 1047, 10.1128/AAC.05054-11 · DOI · Paper page
  34. Falord, 2012b, Investigation of the Staphylococcus aureus GraSR regulon reveals novel links to virulence, stress response and cell wall signal transduction pathways, PLoS ONE, 6, e21323, 10.1371/journal.pone.0021323 · DOI · Paper page
  35. Fedtke, 2007, A Staphylococcus aureus ypfP mutant with strongly reduced lipoteichoic acid (LTA) content: LTA governs bacterial surface properties and autolysin activity, Mol. Microbiol., 65, 1078, 10.1111/j.1365-2958.2007.05854.x · DOI · Paper page
  36. Feng, 2013, Trapping and proteomic identification of cellular substrates of the ClpP protease in Staphylococcus aureus, J. Proteome Res., 12, 547, 10.1021/pr300394r · DOI
  37. Foucault, 2009, Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 53, 2354, 10.1128/AAC.01702-08 · DOI
  38. Frees, 2014, Clp chaperones and proteases are central in stress survival, virulence and antibiotic resistance of Staphylococcus aureus, Int. J. Med. Microbiol., 304, 142, 10.1016/j.ijmm.2013.11.009 · DOI · Paper page
  39. Fridman, 2013, Two unique phosphorylation-driven signaling pathways crosstalk in Staphylococcus aureus to modulate the cell-wall charge: Stk1/Stp1 meets GraSR, Biochemistry, 52, 7975, 10.1021/bi401177n · DOI
  40. Gao, 2013, The RpoB H(4)(8)(1)Y rifampicin resistance mutation and an active stringent response reduce virulence and increase resistance to innate immune responses in Staphylococcus aureus, J. Infect. Dis., 207, 929, 10.1093/infdis/jis772 · DOI
  41. Gardete, 2012, Genetic pathway in acquisition and loss of vancomycin resistance in a methicillin resistant Staphylococcus aureus (MRSA) strain of clonal type USA300, PLoS Pathog., 8, e1002505, 10.1371/journal.ppat.1002505 · DOI · Paper page
  42. Gardete, 2006, Role of VraSR in antibiotic resistance and antibiotic-induced stress response in Staphylococcus aureus, Antimicrob. Agents Chemother., 50, 3424, 10.1128/AAC.00356-06 · DOI · Paper page
  43. Graham, 2013, Trapping and identification of cellular substrates of the Staphylococcus aureus ClpC chaperone, J. Bacteriol., 195, 4506, 10.1128/JB.00758-13 · DOI
  44. Gründling, 2007, Genes required for glycolipid synthesis and lipoteichoic acid anchoring in Staphylococcus aureus, J. Bacteriol., 189, 2521, 10.1128/JB.01683-06 · DOI · Paper page
  45. Hanaki, 1998, Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50, J. Antimicrob. Chemother., 42, 199, 10.1093/jac/42.2.199 · DOI · Paper page
  46. Hartmann, 2013, Catabolite control protein E (CcpE) is a LysR-type transcriptional regulator of tricarboxylic acid cycle activity in Staphylococcus aureus, J. Biol. Chem., 288, 36116, 10.1074/jbc.M113.516302 · DOI
  47. Hattangady, 2015, Genomic, transcriptomic and metabolomic studies of two well-characterized, laboratory-derived vancomycin-intermediate Staphylococcus aureus strains derived from the same parent strain, Antibiotics (Basel), 4, 76, 10.3390/antibiotics4010076 · DOI
  48. Hiramatsu, 1997a, Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin, Lancet, 350, 1670, 10.1016/S0140-6736(97)07324-8 · DOI · Paper page
  49. Hiramatsu, 1997b, Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility, J. Antimicrob. Chemother., 40, 135, 10.1093/jac/40.1.135 · DOI · Paper page
  50. Horne, 2009, Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA, Antimicrob. Agents Chemother., 53, 3447, 10.1128/AAC.01365-08 · DOI
  51. Howden, 2011, Evolution of multidrug resistance during Staphylococcus aureus infection involves mutation of the essential two component regulator WalKR, PLoS Pathog., 7, e1002359, 10.1371/journal.ppat.1002359 · DOI · Paper page
  52. Howden, 2014, The evolution of vancomycin intermediate Staphylococcus aureus (VISA) and heterogenous-VISA, Infect. Genet. Evol., 21, 575, 10.1016/j.meegid.2013.03.047 · DOI · Paper page
  53. Howden, 2008, Genomic analysis reveals a point mutation in the two-component sensor gene graS that leads to intermediate vancomycin resistance in clinical Staphylococcus aureus, Antimicrob. Agents Chemother., 52, 3755, 10.1128/AAC.01613-07 · DOI
  54. Hu, 2015, Mechanism of reduced vancomycin susceptibility conferred by walK mutation in community-acquired methicillin-resistant Staphylococcus aureus strain MW2, Antimicrob. Agents Chemother., 59, 1352, 10.1128/AAC.04290-14 · DOI
  55. Hübscher, 2009, MsrR contributes to cell surface characteristics and virulence in Staphylococcus aureus, FEMS Microbiol. Lett., 295, 251, 10.1111/j.1574-6968.2009.01603.x · DOI
  56. Ingavale, 2003, Characterization of RAT, an autolysis regulator in Staphylococcus aureus, Mol. Microbiol., 48, 1451, 10.1046/j.1365-2958.2003.03503.x · DOI
  57. Ishii, 2015, Phenotypic and genomic comparisons of highly vancomycin-resistant Staphylococcus aureus strains developed from multiple clinical MRSA strains by in vitro mutagenesis, Sci. Rep., 5, 17092, 10.1038/srep17092 · DOI
  58. Jansen, 2007, Role of insertion elements and yycFG in the development of decreased susceptibility to vancomycin in Staphylococcus aureus, Int. J. Med. Microbiol., 297, 205, 10.1016/j.ijmm.2007.02.002 · DOI · Paper page
  59. Jousselin, 2013, The Staphylococcus aureus thiol/oxidative stress global regulator Spx controls trfA, a gene implicated in cell wall antibiotic resistance, Antimicrob. Agents Chemother., 57, 3283, 10.1128/AAC.00220-13 · DOI
  60. Kahne, 2005, Glycopeptide and lipoglycopeptide antibiotics, Chem. Rev., 105, 425, 10.1021/cr030103a · DOI · Paper page
  61. Kajimura, 2005, Identification and molecular characterization of an N-acetylmuramyl-L-alanine amidase Sle1 involved in cell separation of Staphylococcus aureus, Mol. Microbiol., 58, 1087, 10.1111/j.1365-2958.2005.04881.x · DOI · Paper page
  62. Katayama, 2009, Selection of heterogeneous vancomycin-intermediate Staphylococcus aureus by imipenem, Antimicrob. Agents Chemother., 53, 3190, 10.1128/AAC.00834-08 · DOI
  63. Katayama, 2016, Complete reconstitution of the vancomycin-intermediate Staphylococcus aureus phenotype of strain Mu50 in vancomycin-susceptible S. aureus, Antimicrob. Agents Chemother., 60, 3730, 10.1128/AAC.00420-16 · DOI · Paper page
  64. Kato, 2010, Genetic changes associated with glycopeptide resistance in Staphylococcus aureus: predominance of amino acid substitutions in YvqF/VraSR, J. Antimicrob. Chemother., 65, 37, 10.1093/jac/dkp394 · DOI
  65. Kato, 2008, Microbiological and clinical study of methicillin-resistant Staphylococcus aureus (MRSA) carrying VraS mutation: changes in susceptibility to glycopeptides and clinical significance, Int. J. Antimicrob. Agents, 31, 64, 10.1016/j.ijantimicag.2007.08.012 · doi:10.1016/j.ijantimicag.2007.08.012
  66. Kuroda, 2003, Two-component system VraSR positively modulates the regulation of cell-wall biosynthesis pathway in Staphylococcus aureus, Mol. Microbiol., 49, 807, 10.1046/j.1365-2958.2003.03599.x · DOI · Paper page
  67. Kuroda, 2000, Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method, Biochem. Biophys. Res. Commun., 269, 485, 10.1006/bbrc.2000.2277 · DOI · Paper page
  68. Leiba, 2012, A novel mode of regulation of the Staphylococcus aureus catabolite control protein A (CcpA) mediated by Stk1 protein phosphorylation, J. Biol. Chem., 287, 43607, 10.1074/jbc.M112.418913 · DOI
  69. Levine, 2006, Vancomycin: a history, Clin. Infect. Dis., 42, S5, 10.1086/491709 · DOI · Paper page
  70. Liebeke, 2010, A metabolomic view of Staphylococcus aureus and its ser/thr kinase and phosphatase deletion mutants: involvement in cell wall biosynthesis, Chem. Biol., 17, 820, 10.1016/j.chembiol.2010.06.012 · DOI
  71. Limbago, 2014, Report of the 13th vancomycin-resistant Staphylococcus aureus isolate from the United States, J. Clin. Microbiol., 52, 998, 10.1128/JCM.02187-13 · DOI · Paper page
  72. Ling, 2014, A new antibiotic kills pathogens without detectable resistance, Nature, 517, 455, 10.1038/nature14098 · DOI · Paper page
  73. Liu, 2016, SpoVG regulates cell wall metabolism and oxacillin resistance in methicillin-resistant Staphylococcus aureus strain N315, Antimicrob. Agents Chemother., 60, 3455, 10.1128/AAC.00026-16 · doi:10.1128/aac.00026-16
  74. Majcherczyk, 2008, Development of glycopeptide-intermediate resistance by Staphylococcus aureus leads to attenuated infectivity in a rat model of endocarditis, Microb. Pathog., 45, 408, 10.1016/j.micpath.2008.09.003 · DOI
  75. Maki, 2004, tcaA inactivation increases glycopeptide resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 48, 1953, 10.1128/AAC.48.6.1953-1959.2004 · DOI
  76. Manna, 2004, Identification of sarV (SA2062), a new transcriptional regulator, is repressed by SarA and MgrA (SA0641) and involved in the regulation of autolysis in Staphylococcus aureus, J. Bacteriol., 186, 5267, 10.1128/JB.186.16.5267-5280.2004 · DOI · Paper page
  77. Matsuo, 2014, Comprehensive identification of mutations responsible for heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA)-to-VISA conversion in laboratory-generated VISA strains derived from hVISA clinical strain Mu3, Antimicrob. Agents Chemother., 57, 5843, 10.1128/AAC.00425-13 · DOI
  78. Matsuo, 2011, Mutation of RNA polymerase beta subunit (rpoB) promotes hVISA-to-VISA phenotypic conversion of strain Mu3, Antimicrob. Agents Chemother., 55, 4188, 10.1128/AAC.00398-11 · DOI
  79. McAleese, 2006, Overexpression of genes of the cell wall stimulon in clinical isolates of Staphylococcus aureus exhibiting vancomycin-intermediate-S. aureus-type resistance to vancomycin, J. Bacteriol., 188, 1120, 10.1128/JB.188.3.1120-1133.2006 · DOI · Paper page
  80. McCallum, 2011, Mutational analyses of open reading frames within the vraSR operon and their roles in the cell wall stress response of Staphylococcus aureus, Antimicrob. Agents Chemother., 55, 1391, 10.1128/AAC.01213-10 · DOI
  81. McEvoy, 2013, Decreased vancomycin susceptibility in Staphylococcus aureus caused by IS256 tempering of WalKR expression, Antimicrob. Agents Chemother., 57, 3240, 10.1128/AAC.00279-13 · DOI
  82. Meehl, 2007, Interaction of the GraRS two-component system with the VraFG ABC transporter to support vancomycin-intermediate resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 2679, 10.1128/AAC.00209-07 · DOI · Paper page
  83. Melo-Cristino, 2013, First case of infection with vancomycin-resistant Staphylococcus aureus in Europe, Lancet, 382, 205, 10.1016/S0140-6736(13)61219-2 · DOI
  84. Moellering, 2006, Vancomycin: a 50-year reassessment, Clin. Infect. Dis., 42, S3, 10.1086/491708 · DOI · Paper page
  85. Moravvej, 2013, Update on the global number of vancomycin-resistant Staphylococcus aureus (VRSA) strains, Int. J. Antimicrob. Agents, 42, 370, 10.1016/j.ijantimicag.2013.06.004 · doi:10.1016/j.ijantimicag.2013.06.004
  86. Murray, 2000, Vancomycin-resistant enterococcal infections, N. Engl. J. Med., 342, 710, 10.1056/NEJM200003093421007 · DOI · Paper page
  87. Mwangi, 2007, Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing, Proc. Natl. Acad. Sci. U.S.A., 104, 9451, 10.1073/pnas.0609839104 · DOI · Paper page
  88. Nannini, 2010, Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus, Curr. Opin. Pharmacol., 10, 516, 10.1016/j.coph.2010.06.006 · DOI · Paper page
  89. Nelson, 2007, Vancomycin-intermediate Staphylococcus aureus strains have impaired acetate catabolism: implications for polysaccharide intercellular adhesin synthesis and autolysis, Antimicrob. Agents Chemother., 51, 616, 10.1128/AAC.01057-06 · DOI · Paper page
  90. Neoh, 2008, Mutated response regulator graR is responsible for phenotypic conversion of Staphylococcus aureus from heterogeneous vancomycin-intermediate resistance to vancomycin-intermediate resistance, Antimicrob. Agents Chemother., 52, 45, 10.1128/AAC.00534-07 · DOI
  91. Nordmann, 2007, Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010, Curr. Opin. Microbiol., 10, 436, 10.1016/j.mib.2007.07.004 · DOI · Paper page
  92. Ohlsen, 2010, The impact of serine/threonine phosphorylation in Staphylococcus aureus, Int. J. Med. Microbiol., 300, 137, 10.1016/j.ijmm.2009.08.016 · DOI
  93. Passalacqua, 2012, A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin, Antimicrob. Agents Chemother., 56, 5212, 10.1128/AAC.05770-11 · DOI
  94. Peleg, 2009, Reduced susceptibility to vancomycin influences pathogenicity in Staphylococcus aureus infection, J. Infect. Dis., 199, 532, 10.1086/596511 · DOI · Paper page
  95. Pereira, 2007, Fluorescence ratio imaging microscopy shows decreased access of vancomycin to cell wall synthetic sites in vancomycin-resistant Staphylococcus aureus, Antimicrob. Agents Chemother., 51, 3627, 10.1128/AAC.00431-07 · DOI
  96. Pillai, 2009, Development of reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus, Clin. Infect. Dis., 49, 1169, 10.1086/605636 · DOI
  97. Reichmann, 2014, Differential localization of LTA synthesis proteins and their interaction with the cell division machinery in Staphylococcus aureus, Mol. Microbiol., 92, 273, 10.1111/mmi.12551 · DOI
  98. Renzoni, 2011, Whole genome sequencing and complete genetic analysis reveals novel pathways to glycopeptide resistance in Staphylococcus aureus, PLoS ONE, 6, e21577, 10.1371/journal.pone.0021577 · DOI
  99. Renzoni, 2009, Identification by genomic and genetic analysis of two new genes playing a key role in intermediate glycopeptide resistance in Staphylococcus aureus, Antimicrob. Agents Chemother., 53, 903, 10.1128/AAC.01287-08 · DOI
  100. Reynolds, 2012, Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07, J. Antimicrob. Chemother., 67, 2912, 10.1093/jac/dks324 · doi:10.1093/jac/dks324
  101. Robert, 2006, Decreased susceptibility to glycopeptides in methicillin-resistant Staphylococcus aureus: a 20 year study in a large French teaching hospital, 1983-2002, J. Antimicrob. Chemother., 57, 506, 10.1093/jac/dki486 · DOI
  102. Rubinstein, 2014, Vancomycin revisited - 60 years later, Front. Public Health, 2, 10.3389/fpubh.2014.00217 · DOI · Paper page
  103. Ruggiero, 2012, Bacterial cell division regulation by Ser/Thr kinases: a structural perspective, Curr. Protein Pept. Sci., 13, 756, 10.2174/138920312804871201 · DOI
  104. Rybak, 2005, Clinical isolates of Staphylococcus aureus from 1987 and 1989 demonstrating heterogeneous resistance to vancomycin and teicoplanin, Diagn. Microbiol. Infect. Dis., 51, 119, 10.1016/j.diagmicrobio.2004.09.005 · DOI
  105. Sader, 2009, Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006, Antimicrob. Agents Chemother., 53, 4127, 10.1128/AAC.00616-09 · DOI
  106. Samanta, 2014, The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains, Antimicrob. Agents Chemother., 58, 6685, 10.1128/AAC.03280-14 · DOI
  107. Sambanthamoorthy, 2006, Identification and characterization of msa (SA1233), a gene involved in expression of SarA and several virulence factors in Staphylococcus aureus, Microbiology (Reading Engl)., 152, 2559, 10.1099/mic.0.29071-0 · DOI
  108. Schlag, 2010, Role of staphylococcal wall teichoic acid in targeting the major autolysin Atl, Mol. Microbiol., 75, 864, 10.1111/j.1365-2958.2009.07007.x · DOI · Paper page
  109. Schulthess, 2009, Functional characterization of the sigmaB-dependent yabJ-spoVG operon in Staphylococcus aureus: role in methicillin and glycopeptide resistance, Antimicrob. Agents Chemother., 53, 1832, 10.1128/AAC.01255-08 · DOI
  110. Schumacher, 2007, Structural mechanism for the fine-tuning of CcpA function by the small molecule effectors glucose 6-phosphate and fructose 1,6-bisphosphate, J. Mol. Biol., 368, 1042, 10.1016/j.jmb.2007.02.054 · DOI
  111. Schwaber, 2003, Clinical implications of varying degrees of vancomycin susceptibility in methicillin-resistant Staphylococcus aureus bacteremia, Emerging Infect. Dis., 9, 657, 10.3201/eid0906.030001 · DOI
  112. Seidl, 2009, Effect of a glucose impulse on the CcpA regulon in Staphylococcus aureus, BMC Microbiol., 9, 95, 10.1186/1471-2180-9-95 · DOI · Paper page
  113. Seidl, 2006, Staphylococcus aureus CcpA affects virulence determinant production and antibiotic resistance, Antimicrob. Agents Chemother., 50, 1183, 10.1128/AAC.50.4.1183-1194.2006 · DOI · Paper page
  114. Sengupta, 2012, Chromatin immunoprecipitation identifies genes under direct VraSR regulation in Staphylococcus aureus, Can. J. Microbiol., 58, 703, 10.1139/w2012-043 · doi:10.1139/w2012-043
  115. Shang, 2016, Comparative fitness and determinants for the characteristic drug resistance of ST239-MRSA-III-t030 and ST239-MRSA-III-t037 strains isolated in China, Microb. Drug Resist., 22, 185, 10.1089/mdr.2015.0226 · DOI
  116. Shoji, 2011, walK and clpP mutations confer reduced vancomycin susceptibility in Staphylococcus aureus, Antimicrob. Agents Chemother., 55, 3870, 10.1128/AAC.01563-10 · DOI
  117. Sieradzki, 2003, Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus, J. Bacteriol., 185, 7103, 10.1128/JB.185.24.7103-7110.2003 · DOI · Paper page
  118. Sun, 2012, Protein cysteine phosphorylation of SarA/MgrA family transcriptional regulators mediates bacterial virulence and antibiotic resistance, Proc. Natl. Acad. Sci. U.S.A., 109, 15461, 10.1073/pnas.1205952109 · DOI · Paper page
  119. Sun, 2013, Modulation of cell wall synthesis and susceptibility to vancomycin by the two-component system AirSR in Staphylococcus aureus NCTC8325, BMC Microbiol., 13, 286, 10.1186/1471-2180-13-286 · DOI
  120. Tamber, 2010, Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillin-resistant Staphylococcus aureus strain USA300, Infect. Immun., 78, 3637, 10.1128/IAI.00296-10 · DOI
  121. Utaida, 2006, Autolytic properties of glycopeptide-intermediate Staphylococcus aureus Mu50, Antimicrob. Agents Chemother., 50, 1541, 10.1128/AAC.50.4.1541-1545.2006 · DOI
  122. Van Hal, 2014, In vivo evolution of antimicrobial resistance in a series of Staphylococcus aureus patient isolates: the entire picture or a cautionary tale?, J. Antimicrob. Chemother., 69, 363, 10.1093/jac/dkt354 · DOI
  123. Vidaillac, 2013, Alternative mutational pathways to intermediate resistance to vancomycin in methicillin-resistant Staphylococcus aureus, J. Infect. Dis., 208, 67, 10.1093/infdis/jit127 · DOI
  124. Walters, 2015, Vancomycin-resistant Staphylococcus aureus - Delaware, 2015, Morb. Mortal. Wkly. Rep., 64, 1056, 10.15585/mmwr.mm6437a6 · doi:10.15585/mmwr.mm6437a6
  125. Yamakawa, 2012, Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study, J. Infect. Chemother., 18, 406, 10.1007/s10156-011-0330-2 · DOI
  126. Zhang, 2013, First report of a sequence type 239 vancomycin-intermediate Staphylococcus aureus isolate in Mainland China, Diagn. Microbiol. Infect. Dis., 77, 64, 10.1016/j.diagmicrobio.2013.06.008 · DOI
  127. Zhou, 2012, Molecular characterization of rifampicin-resistant Staphylococcus aureus isolates in a Chinese teaching hospital from Anhui, China, BMC Microbiol., 12, 240, 10.1186/1471-2180-12-240 · DOI
  128. Zhu, 2013, pSK41-like plasmid is necessary for Inc18-like vanA plasmid transfer from Enterococcus faecalis to Staphylococcus aureus in vitro, Antimicrob. Agents Chemother., 57, 212, 10.1128/AAC.01587-12 · DOI
  129. Zhuo, 2013, Glycopeptide minimum inhibitory concentration creep among meticillin-resistant Staphylococcus aureus from 2006-2011 in China, Int. J. Antimicrob. Agents, 41, 578, 10.1016/j.ijantimicag.2013.02.014 · doi:10.1016/j.ijantimicag.2013.02.014

Cited by

Metadata

Authors
Hu, Q., Peng, H., & Rao, X.
Venue
Frontiers in Microbiology
Published
2016-10-13
Volume
7
ISSN
1664-302X
Cited by
132
References
1
Funders
National Natural Science Foundation of China (81471993, 81672071)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.